{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:01:31Z","timestamp":1768514491482,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.leukres.2025.108156","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:53:39Z","timestamp":1766422419000},"page":"108156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genomic profiles of myelodysplastic neoplasm with bone marrow eosinophilia or basophilia: Inflammatory drivers and DNA damage response"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-7168","authenticated-orcid":false,"given":"Yujin","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0351-8517","authenticated-orcid":false,"given":"Su Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-4467","authenticated-orcid":false,"given":"Sooyong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja-Yoon","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-9635","authenticated-orcid":false,"given":"Seon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9010-5281","authenticated-orcid":false,"given":"Yoon Hwan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon-Woo","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-5954","authenticated-orcid":false,"given":"Hongseok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.leukres.2025.108156_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0074-02761997000800006","article-title":"Bone marrow contribution to eosinophilic inflammation","volume":"92","author":"Denburg","year":"1997","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.leukres.2025.108156_bib2","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1067\/mai.2000.110156","article-title":"Systemic aspects of allergic disease: bone marrow responses","volume":"106","author":"Denburg","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.leukres.2025.108156_bib3","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/blood-2002-03-0947","article-title":"Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia","volume":"101","author":"Matsushima","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.1995.tb03405.x","article-title":"Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study","volume":"90","author":"Ma","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.108156_bib5","article-title":"Acute myeloid leukemia with basophilic differentiation transformed from myelodysplastic syndrome","volume":"2017","author":"Tanaka","year":"2017","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.leukres.2025.108156_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3346\/jkms.1999.14.4.448","article-title":"Myelodysplastic syndrome that progressed to acute myelomonocytic leukemia with eosinophilia showing peculiar chromosomal abnormality: a case report","volume":"14","author":"Kim","year":"1999","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.leukres.2025.108156_bib7","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.3389\/fimmu.2018.03031","article-title":"Severe eosinophilia in myelodysplastic syndrome with a defined and rare cytogenetic abnormality","volume":"9","author":"Rai","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2025.108156_bib8","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ajh.27306","article-title":"Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study","volume":"99","author":"Groh","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2025.108156_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ajcp\/aqaa244","article-title":"Eosinophilia\/hypereosinophilia in the setting of reactive and idiopathic causes, well-defined myeloid or lymphoid leukemias, or germline disorders","volume":"155","author":"Kelemen","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2025.108156_bib10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1101\/gad.1291305","article-title":"PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints","volume":"19","author":"Lu","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2025.108156_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2025.108156_bib12","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.1815309","article-title":"The combined status of ATM and p53 link tumor development with therapeutic response","volume":"23","author":"Jiang","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2025.108156_bib13","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/sj.onc.1203015","article-title":"Regulation of p53 in response to DNA damage","volume":"18","author":"Lakin","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2025.108156_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.leukres.2014.10.006","article-title":"The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes","volume":"39","author":"Zhang","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2025.108156_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjh.12203","article-title":"TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis","volume":"160","author":"Kulasekararaj","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.108156_bib16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2025.108156_bib17","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1200\/JCO.2016.67.3616","article-title":"Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation","volume":"34","author":"Della Porta","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.108156_bib18","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.18632\/oncotarget.23882","article-title":"Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic\/myeloproliferative neoplasms","volume":"9","author":"Montalban-Bravo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2025.108156_bib19","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/leu.2016.74","article-title":"High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS\/AML cohort","volume":"30","author":"Goel","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2025.108156_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106729","article-title":"Prognostic significance of ATM mutations in chronic lymphocytic leukemia: a meta-analysis","volume":"111","author":"Baghaei Vaji","year":"2021","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2025.108156_bib21","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM mutations in cancer: therapeutic implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2025.108156_bib22","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.dnarep.2014.01.010","article-title":"Functional overlaps between XLF and the ATM-dependent DNA double strand break response","volume":"16","author":"Kumar","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.leukres.2025.108156_bib24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/eji.1830260715","article-title":"Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7","volume":"26","author":"Ray","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.leukres.2025.108156_bib25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.V87.4.1317.bloodjournal8741317","article-title":"The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro","volume":"87","author":"Rusten","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2025.108156_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.leu.2401130","article-title":"Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product","volume":"12","author":"Kiyoi","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2025.108156_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines","volume":"19","author":"Hayakawa","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2025.108156_bib29","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood.V96.12.3907","article-title":"Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways","volume":"96","author":"Mizuki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood-2002-03-0740","article-title":"Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells","volume":"101","author":"Buitenhuis","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2022.106790","article-title":"The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients","volume":"113","author":"Sumiyoshi","year":"2022","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2025.108156_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2025.108156_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc1046","article-title":"Radical causes of cancer","volume":"3","author":"Hussain","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2025.108156_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41584-022-00905-1","article-title":"Inflammation and DNA damage: cause, effect or both","volume":"19","author":"Pezone","year":"2023","journal-title":"Nat. Rev. Rheum."},{"key":"10.1016\/j.leukres.2025.108156_bib35","first-page":"3035","article-title":"Spontaneous tumor formation in Trp53-deficient epidermis mediated by chromosomal instability and inflammation","volume":"29","author":"Mart\u00ednez-Cruz","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.leukres.2025.108156_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1947601911409747","article-title":"Inflammation and p53: a tale of two stresses","volume":"2","author":"Gudkov","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.leukres.2025.108156_bib37","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.188.9.1739","article-title":"Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation","volume":"188","author":"Yang","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2025.108156_bib38","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/sj.onc.1205426","article-title":"p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3","volume":"21","author":"Lin","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2025.108156_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2016.03.010","article-title":"Loss of P53 function activates JAK2-STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient survival","volume":"151","author":"W\u00f6rmann","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.leukres.2025.108156_bib40","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.apsb.2025.03.041","article-title":"Targeting the JAK2\u2013STAT3\u2013UCHL3\u2013ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer","volume":"15","author":"Xin","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.leukres.2025.108156_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41375-018-0342-3","article-title":"Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia","volume":"33","author":"Cross","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2025.108156_bib42","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2015-06-654277","article-title":"Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome","volume":"127","author":"Walker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib43","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1182\/bloodadvances.2021004237","article-title":"A novel activating JAK1 mutation in chronic eosinophilic leukemia","volume":"5","author":"Shomali","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2025.108156_bib44","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.4049\/jimmunol.173.10.6409","article-title":"IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils","volume":"173","author":"Stout","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2025.108156_bib45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcmd.2019.02.002","article-title":"Acute basophilic leukemia with U2AF1 mutation","volume":"76","author":"Carruale","year":"2019","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.leukres.2025.108156_bib47","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108156_bib48","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2012.08.027","article-title":"NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells","volume":"37","author":"Masters","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2025.108156_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fonc.2016.00151","article-title":"Unraveling the pathogenesis of MDS: the NLRP3 inflammasome and pyroptosis drive the MDS phenotype","volume":"6","author":"Sallman","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.leukres.2025.108156_bib50","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fimmu.2016.00502","article-title":"Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment","volume":"7","author":"Kovtonyuk","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2025.108156_bib51","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?","volume":"8","author":"Fulop","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2025.108156_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026154","article-title":"Experimental ASXL1-mediated clonal hematopoiesis promotes inflammation and accelerates heart failure","volume":"11","author":"Min","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.leukres.2025.108156_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0165-4608(94)00138-2","article-title":"Hypereosinophilia associated with monosomy 7","volume":"80","author":"Viniou","year":"1995","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.leukres.2025.108156_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-4608(99)00069-2","article-title":"Myelodysplastic syndrome with atypical eosinophilia in association with ring chromosome 7. A case report","volume":"115","author":"Bakotic","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.leukres.2025.108156_bib55","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","article-title":"TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML","volume":"6","author":"Weinberg","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2025.108156_bib56","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1080\/10428194.2019.1630619","article-title":"Myelodysplastic\/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome","volume":"60","author":"Turner","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2025.108156_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0165-4608(95)00021-6","article-title":"Acute myeloblastic leukemia (M2) with translocation (7;11) followed by marked eosinophilia and additional abnormalities of chromosome 5","volume":"83","author":"Abe","year":"1995","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.leukres.2025.108156_bib58","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1158\/0008-5472.CAN-09-0939","article-title":"Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapy","volume":"69","author":"Cavelier","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2025.108156_bib59","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2025.108156_bib60","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.3324\/haematol.2015.127985","article-title":"Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia","volume":"100","author":"Meggendorfer","year":"2015","journal-title":"Haematologica"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:48:30Z","timestamp":1768459710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625006460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":60,"alternative-id":["S0145212625006460"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108156","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic profiles of myelodysplastic neoplasm with bone marrow eosinophilia or basophilia: Inflammatory drivers and DNA damage response","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108156"}}